Buprenorphine over methadone, with trauma-focused therapy started alongside rather than after: MN665's Unit 8 case study breaks the loop between a composite aide's PTSD and opioid use. Searches like "mn 665 unit 8 assignment example", "mn665 unit 8 sample" and "mn665 unit 8 example" land here.
What a finished MN665 Unit 8 substance use case study looks like
About five pages across four parts: formulation, medication choice, trauma treatment and safety. The formulation draws the loop as a cycle diagram with four points: intrusive memories at night, use to sleep, withdrawal hyperarousal the next day, and memories intensified by that arousal. It records a PCL-5 score of [54] and daily use for [two] years. The medication part weighs buprenorphine against methadone, credits methadone's retention edge, and chooses buprenorphine because daily clinic dosing would collide with her rotating home visits; it notes that the federal waiver requirement ended at the start of 2023 and that fentanyl exposure complicates induction, leaving the method in brackets. The trauma part cites the COPE trial (Mills et al., 2012) for starting prolonged exposure during substance treatment. Safety covers naloxone, approved for over-the-counter sale in 2023, and her former partner.
How a MN665 Unit 8 example is structured
The case study refuses to treat the conditions in sequence, and it says why in its opening paragraph: waiting for sobriety before addressing trauma leaves the engine of her use running, while treating trauma during active use without medication support invites relapse. So every recommendation is tested against both conditions. Buprenorphine is judged on retention and overdose protection and on whether it steadies the next-day arousal that feeds her PTSD. Prolonged exposure is judged on symptom relief and on whether it raises craving, which COPE did not find. A sleep section follows, since night is where the loop closes. Benzodiazepines are ruled out, citing the boxed warning the FDA added in 2016 against combining them with opioids. The safety section separates overdose risk from the risk her former partner poses, and refers the second to a domestic violence advocate.
One loop, drawn once
Memories, use, withdrawal arousal and stronger memories form a four-point cycle on the first page. Every later recommendation refers back to the point in the cycle it interrupts, which keeps the two diagnoses from drifting into separate plans.
Methadone, credited and declined
Methadone's record on retention is acknowledged in full. The case study declines it for a practical reason tied to her life: daily observed dosing early in treatment would conflict with home visits scheduled across [three] counties.
Fentanyl and the first days
Fentanyl's lingering effect can make a standard buprenorphine start difficult. The case study names that problem, lists the induction approaches the literature describes, and keeps the chosen method in brackets, a decision for the prescriber.
Trauma work without waiting
The COPE trial found integrated prolonged exposure reduced PTSD severity without worsening substance use. On that basis therapy begins during stabilization, with sessions timed away from the late-afternoon window when withdrawal once peaked.
Two kinds of danger
Overdose risk is met with a naloxone kit and a household plan. Her former partner's contact is a separate risk, handled through referral to an advocate and a safety plan she controls, with no assumption that the two risks share a solution.
Where marks go in MN665 Unit 8
The link between the two conditions is the first thing a grader checks. A paper that treats opioid use disorder in one section and PTSD in another, never showing how each feeds the other, has described comorbidity without managing it, and that pattern is priced low. Sequencing is tested as well: deferring trauma treatment until some period of abstinence contradicts the integrated-treatment evidence the unit expects cited. Medication choices must be argued from her circumstances, so buprenorphine chosen without addressing methadone's strengths, or without acknowledging the fentanyl induction problem, loses marks. A benzodiazepine for her sleep draws a safety comment. Stigmatizing language, such as addict or clean urine, costs credit on professionalism. Naloxone left out, an unbracketed induction schedule and no plan regarding her former partner draw smaller comments.
Get a MN665 Unit 8 example written to your instructions
Opioids, alcohol, stimulants or cannabis: say which substance your MN665 Unit 8 case involves and which condition travels with it, then send the case, treatment history and rubric. A free first custom case study is ready within 24-48h, tracing how the two conditions feed each other and testing every recommendation against both.
MN665 Unit 8 questions, answered
Should a substance use case study treat both conditions at once?
In most cases, yes. Integrated treatment, addressing the substance use and the co-occurring condition together, has evidence behind it, including trials of trauma-focused therapy during substance treatment. Show how each condition affects the other and how the plan interrupts that cycle. A plan that postpones one condition should give a specific reason tied to the case.
How should the paper choose between buprenorphine and methadone?
By weighing each against the person's circumstances. Methadone may retain some patients better and suits those needing more structure; buprenorphine allows office-based care and flexible schedules. Consider overdose history, work, transport, prior treatment and patient preference, and state what would favor the other option. Keep induction methods and amounts in brackets; they belong to the prescriber.
What language should a substance use case study avoid?
Terms such as addict, abuser, clean and dirty carry stigma and are increasingly flagged in clinical writing. Use person-first language: a person with opioid use disorder, a negative or positive test, return to use. Graders in many sections treat language as part of professional competence, and consistent, respectful terms also make the clinical reasoning easier to follow.